{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:03:25Z","timestamp":1772165005338,"version":"3.50.1"},"reference-count":61,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute of the National Institutes of Health","award":["1R03 CA223935-01"],"award-info":[{"award-number":["1R03 CA223935-01"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["1R03CA 290549-01"],"award-info":[{"award-number":["1R03CA 290549-01"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["REACH, #U01HL152410"],"award-info":[{"award-number":["REACH, #U01HL152410"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["NIH# UT2GM148086POC"],"award-info":[{"award-number":["NIH# UT2GM148086POC"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["Subaward #FY2025-010"],"award-info":[{"award-number":["Subaward #FY2025-010"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["#25-0039"],"award-info":[{"award-number":["#25-0039"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["#1007549"],"award-info":[{"award-number":["#1007549"]}]},{"name":"Midwest Biomedical Accelerator Consortium (MBArC)\/ NIH Research Evaluation and Commercialization Hub","award":["1R03 CA223935-01"],"award-info":[{"award-number":["1R03 CA223935-01"]}]},{"name":"Midwest Biomedical Accelerator Consortium (MBArC)\/ NIH Research Evaluation and Commercialization Hub","award":["1R03CA 290549-01"],"award-info":[{"award-number":["1R03CA 290549-01"]}]},{"name":"Midwest Biomedical Accelerator Consortium (MBArC)\/ NIH Research Evaluation and Commercialization Hub","award":["REACH, #U01HL152410"],"award-info":[{"award-number":["REACH, #U01HL152410"]}]},{"name":"Midwest Biomedical Accelerator Consortium (MBArC)\/ NIH Research Evaluation and Commercialization Hub","award":["NIH# UT2GM148086POC"],"award-info":[{"award-number":["NIH# UT2GM148086POC"]}]},{"name":"Midwest Biomedical Accelerator Consortium (MBArC)\/ NIH Research Evaluation and Commercialization Hub","award":["Subaward #FY2025-010"],"award-info":[{"award-number":["Subaward #FY2025-010"]}]},{"name":"Midwest Biomedical Accelerator Consortium (MBArC)\/ NIH Research Evaluation and Commercialization Hub","award":["#25-0039"],"award-info":[{"award-number":["#25-0039"]}]},{"name":"Midwest Biomedical Accelerator Consortium (MBArC)\/ NIH Research Evaluation and Commercialization Hub","award":["#1007549"],"award-info":[{"award-number":["#1007549"]}]},{"name":"STARTUP Central Proof of Concept-Continuum Educational Technologies","award":["1R03 CA223935-01"],"award-info":[{"award-number":["1R03 CA223935-01"]}]},{"name":"STARTUP Central Proof of Concept-Continuum Educational Technologies","award":["1R03CA 290549-01"],"award-info":[{"award-number":["1R03CA 290549-01"]}]},{"name":"STARTUP Central Proof of Concept-Continuum Educational Technologies","award":["REACH, #U01HL152410"],"award-info":[{"award-number":["REACH, #U01HL152410"]}]},{"name":"STARTUP Central Proof of Concept-Continuum Educational Technologies","award":["NIH# UT2GM148086POC"],"award-info":[{"award-number":["NIH# UT2GM148086POC"]}]},{"name":"STARTUP Central Proof of Concept-Continuum Educational Technologies","award":["Subaward #FY2025-010"],"award-info":[{"award-number":["Subaward #FY2025-010"]}]},{"name":"STARTUP Central Proof of Concept-Continuum Educational Technologies","award":["#25-0039"],"award-info":[{"award-number":["#25-0039"]}]},{"name":"STARTUP Central Proof of Concept-Continuum Educational Technologies","award":["#1007549"],"award-info":[{"award-number":["#1007549"]}]},{"name":"SDSU-Haarberg Drug, Disease and Delivery Research Center","award":["1R03 CA223935-01"],"award-info":[{"award-number":["1R03 CA223935-01"]}]},{"name":"SDSU-Haarberg Drug, Disease and Delivery Research Center","award":["1R03CA 290549-01"],"award-info":[{"award-number":["1R03CA 290549-01"]}]},{"name":"SDSU-Haarberg Drug, Disease and Delivery Research Center","award":["REACH, #U01HL152410"],"award-info":[{"award-number":["REACH, #U01HL152410"]}]},{"name":"SDSU-Haarberg Drug, Disease and Delivery Research Center","award":["NIH# UT2GM148086POC"],"award-info":[{"award-number":["NIH# UT2GM148086POC"]}]},{"name":"SDSU-Haarberg Drug, Disease and Delivery Research Center","award":["Subaward #FY2025-010"],"award-info":[{"award-number":["Subaward #FY2025-010"]}]},{"name":"SDSU-Haarberg Drug, Disease and Delivery Research Center","award":["#25-0039"],"award-info":[{"award-number":["#25-0039"]}]},{"name":"SDSU-Haarberg Drug, Disease and Delivery Research Center","award":["#1007549"],"award-info":[{"award-number":["#1007549"]}]},{"name":"Colorectal Cancer Alliance","award":["1R03 CA223935-01"],"award-info":[{"award-number":["1R03 CA223935-01"]}]},{"name":"Colorectal Cancer Alliance","award":["1R03CA 290549-01"],"award-info":[{"award-number":["1R03CA 290549-01"]}]},{"name":"Colorectal Cancer Alliance","award":["REACH, #U01HL152410"],"award-info":[{"award-number":["REACH, #U01HL152410"]}]},{"name":"Colorectal Cancer Alliance","award":["NIH# UT2GM148086POC"],"award-info":[{"award-number":["NIH# UT2GM148086POC"]}]},{"name":"Colorectal Cancer Alliance","award":["Subaward #FY2025-010"],"award-info":[{"award-number":["Subaward #FY2025-010"]}]},{"name":"Colorectal Cancer Alliance","award":["#25-0039"],"award-info":[{"award-number":["#25-0039"]}]},{"name":"Colorectal Cancer Alliance","award":["#1007549"],"award-info":[{"award-number":["#1007549"]}]},{"name":"Division of Basic Biomedical Science","award":["1R03 CA223935-01"],"award-info":[{"award-number":["1R03 CA223935-01"]}]},{"name":"Division of Basic Biomedical Science","award":["1R03CA 290549-01"],"award-info":[{"award-number":["1R03CA 290549-01"]}]},{"name":"Division of Basic Biomedical Science","award":["REACH, #U01HL152410"],"award-info":[{"award-number":["REACH, #U01HL152410"]}]},{"name":"Division of Basic Biomedical Science","award":["NIH# UT2GM148086POC"],"award-info":[{"award-number":["NIH# UT2GM148086POC"]}]},{"name":"Division of Basic Biomedical Science","award":["Subaward #FY2025-010"],"award-info":[{"award-number":["Subaward #FY2025-010"]}]},{"name":"Division of Basic Biomedical Science","award":["#25-0039"],"award-info":[{"award-number":["#25-0039"]}]},{"name":"Division of Basic Biomedical Science","award":["#1007549"],"award-info":[{"award-number":["#1007549"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Despite considerable advances to improve colorectal cancer (CRC) survival over the last decade, therapeutic challenges remain due to the rapid metastatic dissemination of primary tumors. This study revealed the apoptotic and anti-growth mechanism of VTD, a previously used anti-hypertensive supplement, can elevate UBXN2A, a known tumor suppressor protein in CRC, and simultaneously enhance intrinsic and extrinsic apoptosis in metastatic cancer cells. Methods and Results: An AOM\/DSS mouse model of CRC showed that UBXN2A haplosufficient (UBXN2A +\/\u2212) mice treated with VTD had less tumor burden than mice with the full UBXN2A gene treated with vehicle. We have previously shown that casein-coated mesoporous silica nanoparticles (MSNs) offer an effective local delivery of drugs at tumor sites. Our findings demonstrate that the high rate of extracellular release of matrix metalloproteinases (MMPs), particularly MMP-7, by metastatic colon cancer cells, triggers the release of VTD from casein-coated mesoporous MSNs. This shows the \u201cZip Code\u201d mechanism for the local enrichment of VTD at the tumor sites. After in vitro drug release verification, two independent mouse experiments, a xenograft and a splenolepatic metastatic mouse model of CRC, were used to evaluate the therapeutic efficacy of VTD-loaded and casein-coated carboxylated mesoporous silica nanoparticles, MSN-COOH\/VTD\/CAS (VTD, 0.2 mg\/kg). Animal experiments revealed that MSN-COOH\/VTD\/CAS (VTD, 0.2 mg\/kg) slows down the progress of tumors. Mass spectrometry (MS) revealed improved pharmacokinetics (PK) profile as MSN-COOH\/VTD\/CAS had less VTD accumulation in non-cancerous organs compared to pure VTD. We further improved nanoparticle targeting and drug release by shifting to calcium-based particles (CBPs). The engineered CBPs demonstrated higher drug-releasing performance. Without the MMPs trigger, MSNs show slow and continuous \u201cdrug leak\u201d over longer period of time whereas CCSMPs stops leakage within an hour. Additionally, CBPs showed higher sensitivity to MMP-7 than MMP-9, enhancing the targetability of CBPs for CRC metastatic tumors with excessive extracellular MMP-7. Conclusions: This study introduces a new platform utilizing nanoparticle-based site-specific delivery of a plant-based anti-metastatic molecule, veratridine, with enhanced safety and therapeutic efficacy for the treatment of metastatic CRC.<\/jats:p>","DOI":"10.3390\/cancers17193253","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:22:08Z","timestamp":1759911728000},"page":"3253","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liver-Specific Nanoparticle-Mediated Delivery and MMP-Triggered Release of Veratridine to Effectively Target Metastatic Colorectal Cancer"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8767-0905","authenticated-orcid":false,"given":"Mahadi","family":"Hasan","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-6175","authenticated-orcid":false,"given":"Morgan","family":"Eikanger","sequence":"additional","affiliation":[{"name":"Division of Biomedical and Translational Sciences, Sanford School of Medicine, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Sane","sequence":"additional","affiliation":[{"name":"Division of Biomedical and Translational Sciences, Sanford School of Medicine, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishantha S. K.","family":"Wijewardhane","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Slunecka","sequence":"additional","affiliation":[{"name":"Division of Biomedical and Translational Sciences, Sanford School of Medicine, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Freeling","sequence":"additional","affiliation":[{"name":"Division of Biomedical and Translational Sciences, Sanford School of Medicine, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khosrow","family":"Rezvani","sequence":"additional","affiliation":[{"name":"Division of Biomedical and Translational Sciences, Sanford School of Medicine, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigoriy","family":"Sereda","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of South Dakota, 414 E Clark Street, Vermillion, SD 57069, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: Incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41588-019-0423-x","article-title":"Quantitative evidence for early metastatic seeding in colorectal cancer","volume":"51","author":"Hu","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamasurg.2014.1756","article-title":"Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975\u20132010","volume":"150","author":"Bailey","year":"2015","journal-title":"JAMA Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","article-title":"Global patterns and trends in colorectal cancer incidence in young adults","volume":"68","author":"Siegel","year":"2019","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molmed.2009.03.003","article-title":"Apoptosis and colorectal cancer: Implications for therapy","volume":"15","author":"Yang","year":"2009","journal-title":"Trends Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"23561","DOI":"10.18632\/oncotarget.4452","article-title":"A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2","volume":"16","author":"Abdullah","year":"2015","journal-title":"Oncotarget"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1118","DOI":"10.1038\/cddis.2014.100","article-title":"Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells","volume":"5","author":"Sane","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12192-015-0661-5","article-title":"Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy","volume":"2","author":"Sane","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/1878-0261.12372","article-title":"UBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cells","volume":"12","author":"Sane","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41388-023-02686-7","article-title":"UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer","volume":"42","author":"Sane","year":"2023","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Esfahanian, N., Knoblich, C.D., Bowman, G.A., and Rezvani, K. (2023). Mortalin: Protein partners, biological impacts, pathological roles, and therapeutic opportunities. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1028519"},{"key":"ref_13","first-page":"4317","article-title":"Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer","volume":"9","author":"Bian","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/acsabm.2c00225","article-title":"DNA\u2013liposome hybrid carriers for triggered cargo release","volume":"5","author":"Baumann","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bayda, S., Adeel, M., Tuccinardi, T., Cordani, M., and Rizzolio, F. (2019). The history of nanoscience and nanotechnology: From chemical\u2013physical applications to nanomedicine. Molecules, 25.","DOI":"10.3390\/molecules25010112"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Haley, B., and Frenkel, E. (2008). Nanoparticles for drug delivery in cancer treatment. Urologic Oncology: Seminars and Original Investigations, Elsevier.","DOI":"10.1016\/j.urolonc.2007.03.015"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev-bioeng-071812-152409","article-title":"Multifunctional nanoparticles for drug delivery and molecular imaging","volume":"15","author":"Bao","year":"2013","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12272-013-0277-1","article-title":"Carbon-based drug delivery carriers for cancer therapy","volume":"37","author":"Lim","year":"2014","journal-title":"Arch. Pharmacal Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13706","DOI":"10.1039\/D2RA01587K","article-title":"Recent progress in the applications of silica-based nanoparticles","volume":"12","author":"Nayl","year":"2022","journal-title":"RSC Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1246\/bcsj.63.988","article-title":"The preparation of alkyltrimethylammonium\u2013kanemite complexes and their conversion to microporous materials","volume":"63","author":"Yanagisawa","year":"1990","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/cm0011559","article-title":"A new property of MCM-41: Drug delivery system","volume":"13","year":"2001","journal-title":"Chem. Mater."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"115049","DOI":"10.1016\/j.addr.2023.115049","article-title":"Biosafety of mesoporous silica nanoparticles; towards clinical translation","volume":"201","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1002\/chem.201500578","article-title":"Mesoporous-silica-functionalized nanoparticles for drug delivery","volume":"21","author":"Giret","year":"2015","journal-title":"Chem.\u2014A Eur. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2400323","DOI":"10.1002\/adhm.202400323","article-title":"Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions","volume":"13","author":"Godakhindi","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1021\/acs.chemrev.5b00456","article-title":"Gated materials for on-command release of guest molecules","volume":"116","author":"Aznar","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Corma, A., Botella, P., and Rivero-Buceta, E. (2022). Silica-based stimuli-responsive systems for antitumor drug delivery and controlled release. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010110"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Klupp, F., Neumann, L., Kahlert, C., Diers, J., Halama, N., Franz, C., Schmidt, T., Koch, M., Weitz, J., and Schneider, M. (2016). Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2515-7"},{"key":"ref_28","first-page":"105","article-title":"MMP7 expression in colorectal tumours of different stages","volume":"28","author":"Polistena","year":"2014","journal-title":"In Vivo"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e24953","DOI":"10.1097\/MD.0000000000024953","article-title":"MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.03.003","article-title":"Roles of matrix metalloproteinase-7 (MMP-7) in cancer","volume":"92","author":"Liao","year":"2021","journal-title":"Clin. Biochem."},{"key":"ref_31","first-page":"144","article-title":"Matrix Metalloproteinase-7 Expression in Colorectal Cancer Liver Metastases","volume":"8","author":"Zeng","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/acs.bioconjchem.1c00416","article-title":"Targeting Colon Cancer Cells with Enzyme-Triggered Casein-Gated Release of Cargo from Mesoporous Silica-Based Nanoparticles","volume":"32","author":"Wijewantha","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2310\/7290.2008.00010","article-title":"Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon","volume":"7","author":"Scherer","year":"2008","journal-title":"Mol. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bbapap.2011.07.008","article-title":"Thermodynamic analysis of ionizable groups involved in the catalytic mechanism of human matrix metalloproteinase 7 (MMP-7)","volume":"1814","author":"Takeharu","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/anie.201004133","article-title":"Enzyme-mediated controlled release systems by anchoring peptide sequences on mesoporous silica supports","volume":"50","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.micromeso.2018.11.030","article-title":"Mesoporous silica nanoparticles capped with graphene quantum dots as multifunctional drug carriers for photo-thermal and redox-responsive release","volume":"278","author":"Gao","year":"2019","journal-title":"Microporous Mesoporous Mater."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.vaccine.2014.06.093","article-title":"Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection","volume":"32","author":"Klonoski","year":"2014","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Walker, J. (2009). The bicinchoninic acid (BCA) assay for protein quantitation. The Protein Protocols Handbook, Humana Press.","DOI":"10.1007\/978-1-59745-198-7_3"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sereda, G., Ahammadullah, A., Wijewantha, N., and Solano, Y.A. (2023). Acid-triggered release of eugenol and fluoride by desensitizing macro-and nanoparticles. J. Funct. Biomater., 14.","DOI":"10.3390\/jfb14010042"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"24075","DOI":"10.18632\/oncotarget.4373","article-title":"Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/laban0511-155","article-title":"Retro-orbital injections in mice","volume":"40","author":"Yardeni","year":"2011","journal-title":"Lab Anim."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16070","DOI":"10.1038\/mtm.2016.70","article-title":"Assessment of murine colorectal cancer by micro-ultrasound using three dimensional reconstruction and non-linear contrast imaging","volume":"5","author":"Freeling","year":"2016","journal-title":"Mol. Ther.\u2014Methods Clin. Dev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4161\/cam.23840","article-title":"Integrins and metastasis","volume":"7","author":"Ganguly","year":"2013","journal-title":"Cell Adhes. Migr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","article-title":"Akt, FoxO and regulation of apoptosis","volume":"1813","author":"Zhang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2174\/1389200219666180511154722","article-title":"The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways","volume":"19","author":"Wang","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Rajabi, S., Maresca, M., Yumashev, A.V., Choopani, R., and Hajimehdipoor, H. (2021). The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy. Biomolecules, 11.","DOI":"10.3390\/biom11040534"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41420-022-00936-3","article-title":"Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model","volume":"8","author":"Freeling","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-3565(25)23046-4","article-title":"Neurotoxic action of veratridine in rat brain neuronal cultures: Mechanism of neuroprotection by Ca++ antagonists nonselective for slow Ca++ channels","volume":"255","author":"Pauwels","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2008.11.041","article-title":"Investigating the in vitro metabolism of veratridine: Characterization of metabolites and involved cytochrome P450 isoforms","volume":"877","author":"Ye","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ame2.12299","article-title":"Patient-derived xenograft model in colorectal cancer basic and translational research","volume":"6","author":"Liu","year":"2023","journal-title":"Anim. Models Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s42826-021-00087-z","article-title":"Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs","volume":"37","author":"Oh","year":"2021","journal-title":"Lab. Anim. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"81156","DOI":"10.18632\/oncotarget.13215","article-title":"Gankyrin sustains PI3K\/GSK-3\u03b2\/\u03b2-catenin signal activation and promotes colorectal cancer aggressiveness and progression","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Walstra, P., Walstra, P., Wouters, J.T., and Geurts, T.J. (2005). Dairy Science and Technology, CRC Press.","DOI":"10.1201\/9781420028010"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Nouri, Z., Fakhri, S., Nouri, K., Wallace, C.E., Farzaei, M.H., and Bishayee, A. (2020). Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach. Cancers, 12.","DOI":"10.3390\/cancers12082276"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1574892810666151020101706","article-title":"Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far","volume":"11","author":"Bordoloi","year":"2016","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.phrs.2017.11.027","article-title":"A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer","volume":"129","author":"Cevatemre","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Islam, M.R., Akash, S., Rahman, M.M., Nowrin, F.T., Akter, T., Shohag, S., Rauf, A., Aljohani, A.S.M., and Simal-Gandara, J. (2022). Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. Chem. Biol. Interact., 368.","DOI":"10.1016\/j.cbi.2022.110170"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Kim, M., Bakyt, L., Akhmetkaliyev, A., Toktarkhanova, D., and Bulanin, D. (2023). Re-Sensitizing Cancer Stem Cells to Conventional Chemotherapy Agents. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032122"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Wang, Q., Shen, X., Chen, G., and Du, J. (2022). Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers, 14.","DOI":"10.3390\/cancers14122928"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","article-title":"Reprogramming Dysfunctional Dendritic Cells by a Versatile Catalytic Dual Oxide Antigen-Captured Nanosponge for Remotely Enhancing Lung Metastasis Immunotherapy","volume":"19","author":"Chiang","year":"2025","journal-title":"ACS Nano"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/19\/3253\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:18:07Z","timestamp":1760069887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/19\/3253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":61,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["cancers17193253"],"URL":"https:\/\/doi.org\/10.3390\/cancers17193253","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}